CTO and MedTech Scientist
Samplimy Medical AB
Samplimy provides painless, self‑administered microsampling devices that collect precise volumes of blood and dermal interstitial fluid from the skin. The collected samples are stabilized in a dry matrix, eliminating biohazard handling and cold‑chain logistics, and can be mailed to laboratories for standard DBS analysis. This cost‑effective solution enables scalable, point‑of‑care diagnostics and large‑scale population health monitoring.
- Biotechnology
- Healthcare Technology
Updated 2 months ago
Funding
Funding not disclosed
across 1 round
KV
RoundDateAmountValuationInvestors
Founders
Product
Features
- Samplimy provides painless, self‑administered microsampling devices that collect precise volumes of blood and dermal interstitial fluid from the skin. The collected samples are stabilized in a dry matrix, eliminating biohazard handling and cold‑chain logistics, and can be mailed to laboratories for standard DBS analysis. This cost‑effective solution enables scalable, point‑of‑care diagnostics and large‑scale population health monitoring.